The abstract is read at the publisher; the summary is JClub's.
Combined agomiR-215-5p/3p treatment in a TNBS-induced murine colitis fibrosis model reduced colonic hydroxyproline by ~55.6% and collagen deposition by ~47.7%.
- Why it matters: Intestinal fibrosis in Crohn’s disease causes strictures and often requires surgery, yet epithelial microRNAs that regulate EMT during established fibrosis are not well defined.
- What they did: The study profiled epithelial-enriched miRNAs in human fibrostenotic CD tissues and used organoids plus mechanistic assays to show miR-215-5p/3p target ZEB2 and STC1, with CREB1 transcriptionally activating them.
- The result: Restoring miR-215-5p/3p suppressed EMT and fibroblast activation in fibrogenic organoid conditions, and in vivo effects were blocked by ZEB2 or STC1 re-expression with mutant 3'UTRs, while miR-215-5p/3p inhibition worsened TNBS-induced fibrosis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.